RiVive™ (naloxone) – New over-the-counter approval
July 28, 2023 - The FDA announced the approval of Harm Reduction Therapeutics over-the-counter (OTC) RiVive (naloxone) nasal spray 3 mg, to revive someone during an overdose from many prescription pain medications or street drugs such as heroin.
Download PDF
